Day: April 10, 2021

ZUG, Switzerland and CAMBRIDGE, Mass., April 10, 2021 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced preclinical data from the Company’s allogeneic chimeric antigen receptor T cell (CAR-T) program at the American Association for Cancer Research (AACR) Annual Meeting 2021. The data, presented today in an e-poster session entitled, CD70 knockout: A novel approach to augment CAR-T cell function, found that the generation of CAR-T cells including knockout of the CD70 show improved properties including potency and persistence over CAR T cells where the CD70 gene remains intact. The Company applied CRISPR/Cas9 editing to examine the effects of knocking out the gene function of multiple checkpoint-related genes...

Saint-Herblain (France), April 10, 2021 – Valneva SE (“Valneva” or the “Company”), a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, announces today the publication of its 2020 Universal Registration Document filed with the French Financial Markets Authority on April 9, 2021 under the filing number D.21-0286.   Valneva’s 2020 Universal Registration Document notably includes the Company’s 2020 Annual Financial Report, Management Board Report, the Supervisory Board’s report on Corporate Governance including information on the conditions of preparation and organization of the Supervisory Board’s work and on the internal control and risk management procedures, information on the amount of fees paid to the Statutory Auditors...

Saint-Herblain (France), 10 avril, 2021 – Valneva SE (“Valneva” ou le “Groupe”), société spécialisée dans le développement et la commercialisation de vaccins prophylactiques contre des maladies infectieuses générant d’importants besoins médicaux, annonce aujourd’hui la publication de son Document d’Enregistrement Universel 2020, à la suite du dépôt de ce document le 9 avril 2021 auprès de l’Autorité des Marchés Financiers (AMF), sous le numéro D.21-0286. Le Document d’Enregistrement Universel 2020 de Valneva contient notamment le Rapport Financier Annuel 2020 du Groupe, le rapport de gestion du Groupe, le rapport du conseil de surveillance sur le gouvernement d’entreprise, y compris des informations sur les conditions de préparation et d’organisation du travail du conseil de surveillance et sur les procédures de contrôle interne et de...

Saint-Herblain (France), April 10, 2021 – Valneva SE (the “Company”), a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, today announced that it has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (the “SEC”) relating to a proposed initial public offering of its American Depositary Shares (“ADSs”), representing ordinary shares, in the United States, and a concurrent offering of its ordinary shares in certain jurisdictions outside of the United States (together, the “Global Offering”). All securities to be sold in the Global Offering will be offered by the Company. The number of ordinary shares to be represented by each ADS, the number of ADSs and ordinary shares to be offered and the...

  Saint-Herblain (France), 10 avril 2021 – Valneva SE (la « Société »), société spécialisée dans le développement et la commercialisation de vaccins prophylactiques contre des maladies infectieuses générant d’importants besoins médicaux a annoncé aujourd’hui le dépôt d’un document d’enregistrement « Form F-1 » auprès de la Securities and Exchange Commission (« SEC ») dans le cadre de son projet d’introduction en bourse envisagée sous la forme d’American Depositary Shares (« ADS ») représentant des actions ordinaires aux États-Unis et dans d’autres pays en dehors des États-Unis et une offre concomitante de ses actions ordinaires (ensemble, l’« Offre Globale »). Tous les titres vendus dans le cadre de l’Offre Globale seront émis par la Société. Le nombre d’actions ordinaires représentées par chaque ADS, le nombre d’ADS et d’actions ordinaires...

Everyone has been anticipating inflation as part of the economic recovery and because of this, tech stocks had been on a thorny path for the past few days. Thursday session opened higher after Powell’s speech Wednesday evening, resulting to a massive tech rally led by Alphabet (GOOGL), Facebook (FB), and Microsoft (MSFT) which all hit new ATH. NASDAQ outperformed and closed to its highest since February, while S&P 500 reached a new all-time peak. The Dow also closed higher with its quiet movements in the market. Futures for the 3 all edged higher with all the positive news coming in. Inflation will be held back as much as possible, economic recovery is underway, and COVID-19 vaccine rollout going smoothly. Here’s a quick view of all the major changes in the market as of Thursday, April 8: • NASDAQ Composite Index jumped 1.03% or 140.47...

On top of that, the minutes of meeting held by the Federal Reserve reiterated that central bank will not be changing policies in the near future. This is to address the unrest of investors about possible inflation. Amidst all this, S&P 500 went ahead and broke their own record, going up today by 0.1%. The Dow Jones Industrial Average also managed to close up by 0.1%, while NASDAQ Composite Index staggered down by 0.1%. Meanwhile, all futures of the 3 major indexes are on the green, with NASDAQ gaining 0.73%, followed by S&P going up by 0.34% and lastly the Dow up by 0.09%. Majority of the U.S. treasury yields went down with only a few, the short term ones, managed to eke out some gains. Here’s the main movements in the stock market this Wednesday; • S&P 500 went up by 0.15% or 6.01 points, ending at the new record high of...

DUBLIN, IRELAND, April 09, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Fast-growing pan-European independent power producer, Alternus Energy Group Plc (NOTC: ALT) (the “Company”, “Alternus” or “AEG”), is pleased to announce the recent issuance of €9 million of convertible notes lead by AVG Group Sarl (AVG), a Luxembourg based asset manager focused on Nordic ESG and Impact™ investing in the Nordics. AVG provided €8 million of the total investment with the remainder being provided by private individuals. “We are delighted to have AVG as a new financing partner and look forward to working with them going forward as we continue to grow Alternus over the next few years in our continuing mission to become one of the largest pan-European solar operators by the end of the decade,” said Vincent Browne, CEO. Alternus decided to move its US...

TORONTO, April 09, 2021 (GLOBE NEWSWIRE) — Digihost Technology Inc. (“Digihost” or the “Company”) (TSXV: DGHI; OTCQB: HSSHF) provides an update today that further to the review by the Ontario Securities Commission (the “OSC”) of the Company’s continuous disclosure and a subsequent request from OSC staff in connection therewith, the Company has filed amended and restated interim consolidated financial statements for the three and nine months ended September 30, 2020 along with a corresponding restated management discussion and analysis. Corrective disclosure was requested by staff of the OSC in connection with its review of the Company’s base shelf prospectus. In accordance with OSC Staff Notice 51-711 (Revised) Refilings and Corrections of Errors (“Notice 51-711”), the Company has filed the documents noted above on SEDAR, which...